Article
The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation.
eLife - 1 Jun 2018
Girnius Nomeda, Edwards Yvonne Jk, Garlick David S, Davis Roger J
Abstract excerpt
Breast cancer is the most commonly diagnosed malignancy in women. Analysis of breast cancer genomic DNA indicates frequent loss-of-function mutations in components of the cJUN NH2-terminal kinase (JNK) signaling pathway. Since JNK signaling can promote cell proliferation by activating the AP1 transcription factor, this apparent association of reduced JNK signaling with tumor development was unexpected. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
